Johnson & Johnson
JNJ
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Bloomberg Markets and Finance • 1 day ago • JNJ
J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine
Zacks Investment Research • 2 days ago • JNJ
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
Business Wire • 3 days ago • JNJ
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
24/7 Wall Street • 3 days ago • JNJ
3 Unstoppable Growth Stocks For Years Of Passive Income
24/7 Wall Street • 4 days ago • JNJ
3 Dividend Kings That Have Outrun the Nasdaq Over 12 Months
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.